![](/img/cover-not-exists.png)
AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogue
G Mathé, P Pontiggia, S Orbach-Arbouys, K Triana, N Ambetima, C Morette, M Hallard, D BlanquetVolume:
50
Year:
1996
Language:
english
Pages:
228
DOI:
10.1016/0753-3322(96)87662-1
File:
PDF, 492 KB
english, 1996